Clinical trials
Phase 2 Aspergillosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2014 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 6 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Astellas Pharma Inc | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Pulmocide Ltd | 2 |
| Basilea Pharmaceutica | 1 |
| Brynn Chappell | 1 |
| Fundació Sant Joan de Déu | 1 |
| Manchester University NHS Foundation Trust | 1 |
| Pfizer | 1 |
| Pulmatrix Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aspergillosis | 21 |
| Mycoses | 5 |
| Candidiasis | 3 |
| Invasive Fungal Infections | 3 |
| Cystic Fibrosis | 2 |
| Invasive Pulmonary Aspergillosis | 2 |
| Pulmonary Aspergillosis | 2 |
| Aspergillosis, Allergic Bronchopulmonary | 1 |
| COVID-19 | 1 |
| Candidiasis, Invasive | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.